The Johns Hopkins Project RESTORE was established over 10 years ago as a collaborative multidisciplinary effort to advance our understanding of and develop new therapies for neuroimmunologic disorders (multiple sclerosis, transverse myelitis and neuromyelitis optica). In practice this has meant forging collaborations and carrying out innovative research designed to profoundly enhance our understanding of these disorders and to translate basic science findings into clinical therapies. By developing new treatments we seek to Restore Hope, Restore Function and Restore Lives to patients and families with these disorders. As we turn the page to 2017 we are excited to launch our e-newsletter, written by our faculty and staff to keep you updated on our research and other activities.

Johns Hopkins hosts an interactive workshop for patients, caregivers and children affected by multiple sclerosis.

Daniel Reich, M.D., Ph.D is recognized for his innovative ways of looking at the brain to advance knowledge of MS. In addition to his primary affiliation at NIH, Dr. Reich is also Adjunct Associate Professor of Neurology and Radiology at the Johns Hopkins School of Medicine.

If you missed the 4th Regional Transverse Mylelitis Symposium on June 25 at Johns Hopkins, here's your chance to catch up on highlights and view the presentations.

In a collaborative effort with scientists at six Colombian hospitals, Johns Hopkins Medicine researchers report what they believe to be the strongest biological evidence to date linking Zika virus infection and Guillain-Barré syndrome.

Organ donations from people living with MS are invaluable gifts to research conducted at the Neuroimmunology Clinic of the National Institute of Neurological Disease and Stroke (NINDS). Here's what you need to know.

In a proof-of-principle study, a team of physicians and bioinformatics experts at Johns Hopkins reports they were able to diagnose or rule out suspected brain infections using so called next-generation genetic sequencing of brain tissue samples.

This month's topics include the impact of precision medicine on MS, new scientific findings on the origins of diseases such as MS and TM and a multidisciplinary approach to rehabilitation for rare neuroinflammatory diseases.

Johns Hopkins' MS Center researcher, Alissa Rothman is honored with MS International Federation’s 2016 Young Investigators Award at recent ECTRIMS conference in London.